Silence Therapeutics to Participate in H.C. Wainwright BioConnect Investor Conference May 12, 2026 Silence Therapeutics plc (Nasdaq: SLN), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today announced that Curtis Rambaran, MD, Chief Medical Officer of Silence Therapeutics, will participate in a fireside chat at the H.C. Wainwright BioConnect Investor Conference on Tuesday, May 19, 2026 at 2:00 p.m. ET. The live webcast can be [...]
Gradiant Delivers HyperSolved, Its AI Data Center Solution, to Leading Global Hyperscalers May 12, 2026 End-to-end platform eliminates water as a constraint to data center growth, replacing legacy, fragmented approaches with a fully integrated infrastructure solution.
KBRA Assigns Preliminary Ratings to Bletchley Park Funding 2026-1 PLC May 12, 2026 KBRA UK (KBRA) assigns preliminary ratings to six classes of notes issued by Bletchley Park Funding 2026-1 PLC, a static UK RMBS securitisation backed by a portfolio of first-ranking buy-to-let (BTL) mortgage loans secured on residential properties in England, Wales, and Northern Ireland. The aggregate balance of the provisional portfolio is £286.0 million as of [...]
GenNx360 Capital Partners Completes Sale of Precision Aviation Group to VSE Corporation for Approximately $2.025 Billion in Cash and Equity. May 12, 2026 GenNx360 Capital Partners (“GenNx360”), a New York-based private equity firm, has announced the sale of its portfolio company, Precision Aviation Group, Inc. (“PAG” or the “Company”), to VSE Corporation (“VSE”) for a total upfront consideration of approximately $2.025 billion in cash and equity. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260512000455/en/ Founded [...]
Alkermes Announces Positive Topline Results From REVITALYZ℠ Phase 3 Study Evaluating LUMRYZ® (sodium oxybate) Extended-Release in Adults With Idiopathic Hypersomnia May 12, 2026 – LUMRYZ Met All Primary and Key Secondary Endpoints Demonstrating Statistically Significant and Clinically Meaningful Improvements Compared to Placebo in Excessive Daytime Sleepiness and Patient-Reported Disease Severity – – Safety Profile Consistent With Known Safety Profile of LUMRYZ –
Telekom Srbija Raises €1.95 Billion Through Landmark Eurobond Transaction, Attracting Record Demand from Global Investors May 12, 2026 The largest corporate bond issuance from the region attracted nearly USD 14 billion in demand from around 300 global institutional investors, marking a milestone moment for Southeast European capital markets.
Goldman Sachs Alternatives Acquires FGI Worldwide May 12, 2026 Transaction Accelerates FGI’s Growth and Expands Product Offering
Only 19% of Major Retail Supply Chain Decisions Are Delivered as Intended May 12, 2026 Step-Change Decisions Are Increasing in Scale, Frequency and Complexity but Are Being Made ‘In the Dark’, New Kallikor Research Finds 9 in 10 leaders expect to deliver at least one step-change decision in the next 12 months 90% say major decisions carry reputational risk 60% rank reputational risk among the top barriers to decision-making 74% say slow decision-making reduces willingness to pursue bold change
Lovevery Introduces The Maths Skill Set, a Hands-On Program Proven to Improve Maths Scores Through Play, Now Available in the UK and Europe May 12, 2026 The screen-free, research-backed approach provides children with a stronger foundation needed to support one of the most important early academic skills.
Valuedynamx Powers Quidco’s New In-Store Cashback Feature, Bringing Seamless Card-Linked Rewards to Millions of UK Members May 12, 2026 Card-linking technology enables Quidco members to earn cashback on everyday purchases at over 50 retailers